|
NAME
Louise Wideroff |
POSITION TITLE
Program Director |
eRA COMMONS USER NAME |
EDUCATION/TRAINING |
INSTITUTION AND LOCATION |
DEGREE
|
YEAR(s) |
FIELD OF STUDY |
National Cancer Institute |
Postdoctoral Fellowship |
1997 |
Cancer Epidemiology |
University of Michigan |
Ph.D. |
1993 |
Epidemiology |
University of Illinois |
M.S.P.H. |
1987 |
Epidemiology |
Antioch University |
B.A. |
1979 |
Foreign Languages |
|
Program Director
National Cancer Institute, Division of Cancer Control and Population Sciences, Applied Research Program, Risk Factor Monitoring and Methods Branch, Rockville, MD (1997-current).
Dr. Wideroff received her PhD in epidemiology from the University of Michigan. Prior to joining the Applied Research Program in 1997, she completed a post-doctoral fellowship in cancer epidemiology in the Division of Cancer Epidemiology and Genetics at NCI.
She is currently is a program director and project officer in the Risk Factors Monitoring and Methods Branch of the Applied Research Program at NCI. Her areas of expertise include assessment and use of family history of cancer information, and clinical utility of emerging cellular, molecular, and genomic technologies in cancer prevention and control. She currently serves as program director for the Program Announcement entitled Understanding the Effects of Emerging Cellular, Molecular, and Genomic Technologies in Cancer Care. She has also served as NCI Project Officer on research contracts addressing family history of cancer accuracy and interpretability, physician use of genetic tests for inherited breast/ovarian and colorectal cancer susceptibility, and cancer risk associated with blood transfusions.
Her interests include molecular and modifiable risk factors for cancer progression, and effectiveness of and access to molecular diagnostic tools and targeted therapies in routine clinical care.
|